Clinical Trials in 2024 – A Preview of Trials Planned to Initiate and Estimated to Complete
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
This report provides a preview of clinical trials that are planned to be initiated and projected to be completed in 2024.
Scope
The clinical trials data used for these analyses were extracted from GlobalData’s Clinical Trials Database. The data included planned clinical trials with a start date from January 1 to December 31, 2024, captured in the database as of December 15, 2023. The planned trials were analyzed and segmented by phase, single versus multinational trials, geography, sponsor type (industry versus non-industry), therapy area, indication, top sponsors, drug type, and DCT use. Clinical trials with an ongoing or planned status with an end date between January 1 and December 31, 2024, were also examined. The trials that are estimated to be completed in 2024 were split by phase, status, indication, sponsor type, top sponsors, geography and DCT use. In this report, a small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials, respectively.
Reasons to Buy
Understand the planned trials landscape and trends for 2024
Provide early insight for studies expected to be completed in 2024
The 2024 trends of DCTs in both planned trials and trials to be completed
Table of Contents
Figures
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.